Immunogenicity of Full Length and Truncated SIV Envelope Proteins
- 1 January 1999
- journal article
- research article
- Published by Mary Ann Liebert Inc in Viral Immunology
- Vol. 12 (3) , 205-215
- https://doi.org/10.1089/vim.1999.12.205
Abstract
We have compared the immunogenicity of the full-length (FL) SIV envelope (Env) protein and a truncated (T) form of the Env protein which has a short cytoplasmic tail. The Env(T) protein was previously shown to be more fusogenic than Env(FL), has a higher level of incorporation into virus-like particles (VLPs) and membrane vesicles, and expands the viral host range. We have found that mice immunized with VLPs which contained an equal amount of Env(FL) or Env(T) produced similar titres of neutralizing antibody. Comparison of immune responses between animals that received DNA vaccines encoding Env(T) vs. Env (FL) by epidermal delivery demonstrated that a higher level of specific antibody was elicited by Env(T) than Env(FL). This result correlated with a higher level of expression of pCMVEnv(T) than pCMVEnv(FL) observed in vitro. DNA immunization combined with VLP boosting elicited a similar level of neutralizing antibody with both forms of Env proteins. These data indicate that the immunogenicity of Env(FL) and Env(T) is similar, and that either form of Env protein appears to be potentially suitable for use in further development of vaccine preparations.Keywords
This publication has 51 references indexed in Scilit:
- Gene gun‐based nucleic acid immunization alone or in combination with recombinant vaccinia vectors suppresses virus burden in rhesus macaques challenged with a heterologous SIVImmunology & Cell Biology, 1997
- Vaccination with HIV-1 gp120 DNA induces immune responses that are boosted by a recombinant gp120 protein subunitVaccine, 1997
- Neutralization of SIVmac239/17E in Lymphocyte Cultures Involves Virus Strain-Specific Linear and Conformational Epitopes Encoded by Different Regions of theenvGene Including the “V3” DomainVirology, 1996
- Differential Role of V3-Specific Antibodies in Neutralization Assays Involving Primary and Laboratory-Adapted Isolates of HIV Type 1AIDS Research and Human Retroviruses, 1995
- A Qualitative Progression in HIV Type 1 Glycoprotein 120-Specific Cytotoxic Cellular and Humoral Immune Responses in Mice Receiving a DNA-Based Glycoprotein 120 VaccineAIDS Research and Human Retroviruses, 1994
- HIV-1 neutralization directed to epitopes other than linear V3 determinantsAIDS, 1991
- Induction of AIDS in Rhesus Monkeys by Molecularly Cloned Simian Immunodeficiency VirusScience, 1990
- SIV adaption to human cellsNature, 1989
- Trans-activation of human immunodeficiency virus occurs via a bimodal mechanismCell, 1986
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970